Health
newsGP – AstraZeneca’s lower efficacy has been questioned, but what about other considerations? – RACGP
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
News
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
The spotlight is on AstraZenecas candidate, co-developed with the University of Oxford, as Australia moves closer to its mid-February vaccine rollout.
As the US, UK and Europe continue to record thousands of daily new cases of COVID-19, it has been said time again that Australia is in an enviable position.The vaccine roadmap is expected to begin with…
-
Business18 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News18 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business14 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News17 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses